Burning Free Cash Flow Yield vs Begin Period Cash Flow Analysis
BNR Stock | USD 3.44 0.16 4.44% |
Burning Rock financial indicator trend analysis is way more than just evaluating Burning Rock Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Burning Rock Biotech is a good investment. Please check the relationship between Burning Rock Free Cash Flow Yield and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Free Cash Flow Yield vs Begin Period Cash Flow
Free Cash Flow Yield vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Burning Rock Biotech Free Cash Flow Yield account and Begin Period Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Burning Rock's Free Cash Flow Yield and Begin Period Cash Flow is -0.67. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Burning Rock Biotech, assuming nothing else is changed. The correlation between historical values of Burning Rock's Free Cash Flow Yield and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Burning Rock Biotech are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Free Cash Flow Yield i.e., Burning Rock's Free Cash Flow Yield and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.67 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most indicators from Burning Rock's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Burning Rock Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Burning Rock Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. As of 11/09/2024, Tax Provision is likely to grow to about 3.4 M, while Selling General Administrative is likely to drop slightly above 327.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 47.8M | 124.1M | 133.4M | 140.1M | Interest Income | 3.5M | 9.5M | 15.3M | 10.0M |
Burning Rock fundamental ratios Correlations
Click cells to compare fundamentals
Burning Rock Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Burning Rock fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 86.8M | 68.6M | 104.2M | 103.9M | 102.4M | 89.6M | |
Total Assets | 847.6M | 2.7B | 2.3B | 1.6B | 1.0B | 1.6B | |
Short Long Term Debt Total | 67.5M | 46.9M | 86.7M | 50.8M | 12.3M | 11.7M | |
Other Current Liab | 54.1M | 83.6M | 127.9M | 173.8M | 104.9M | 105.6M | |
Total Current Liabilities | 164.4M | 241.5M | 372.2M | 411.5M | 263.4M | 318.6M | |
Total Stockholder Equity | (891.5M) | 2.4B | 1.8B | 1.2B | 768.4M | 861.3M | |
Other Liab | 991K | 491K | 11.8M | 4.1M | 4.7M | 4.3M | |
Net Tangible Assets | (891.8M) | 2.4B | 1.8B | 1.2B | 1.3B | 862.0M | |
Property Plant And Equipment Net | 89.3M | 111.5M | 406.4M | 300.0M | 144.2M | 205.5M | |
Current Deferred Revenue | 53.6M | 75.5M | 143.8M | 149.4M | 131.7M | 112.2M | |
Net Debt | (26.8M) | (1.8B) | (1.3B) | (854.7M) | (602.8M) | (632.9M) | |
Retained Earnings | (946.5M) | (1.4B) | (2.2B) | (3.2B) | (3.9B) | (3.7B) | |
Accounts Payable | 12.3M | 35.5M | 63.1M | 50.9M | 18.1M | 36.0M | |
Cash | 94.2M | 1.9B | 1.4B | 905.5M | 615.1M | 923.0M | |
Non Current Assets Total | 140.8M | 139.4M | 457.6M | 328.7M | 155.9M | 238.7M | |
Non Currrent Assets Other | 11.0M | 23.0M | 45.1M | 26.0M | 5.1M | 4.8M | |
Other Assets | 11.0M | 23.0M | 45.1M | 26.0M | 29.9M | 24.8M | |
Cash And Short Term Investments | 408.2M | 2.3B | 1.5B | 905.5M | 615.1M | 1.1B | |
Net Receivables | 208.5M | 111.0M | 134.6M | 151.7M | 167.8M | 156.9M | |
Short Term Investments | 314.0M | 362.1M | 63.8M | 2.1M | 13.4M | 12.7M | |
Liabilities And Stockholders Equity | 847.6M | 2.7B | 2.3B | 1.6B | 1.0B | 1.6B | |
Non Current Liabilities Total | 1.6B | 491K | 61.1M | 17.7M | 8.2M | 7.8M | |
Capital Lease Obligations | 9.7M | 4.8M | 84.3M | 50.8M | 12.3M | 11.7M | |
Inventory | 58.1M | 68.0M | 123.2M | 130.3M | 69.0M | 91.3M | |
Other Current Assets | 1.3M | 57.3M | 60.3M | 51.5M | 2.8M | 2.7M | |
Other Stockholder Equity | (1.5B) | 4.0B | 4.3B | 4.5B | 4.8B | 3.0B | |
Total Liab | 1.7B | 242.0M | 433.3M | 429.1M | 271.6M | 258.0M | |
Net Invested Capital | (833.7M) | 2.5B | 1.8B | 1.2B | 768.4M | 928.4M | |
Long Term Investments | 40.2M | 1.4M | 910K | 690K | 337K | 320.2K | |
Property Plant And Equipment Gross | 89.3M | 111.5M | 406.4M | 300.0M | 548.3M | 279.6M | |
Total Current Assets | 706.8M | 2.5B | 1.8B | 1.3B | 884.1M | 1.4B | |
Accumulated Other Comprehensive Income | 9.3M | (167.6M) | (207.1M) | (165.7M) | (161.5M) | (169.6M) | |
Net Working Capital | 542.3M | 2.3B | 1.4B | 847.3M | 620.7M | 1.1B | |
Short Term Debt | 44.4M | 46.9M | 37.4M | 37.2M | 8.6M | 8.2M | |
Intangible Assets | 343K | 3.5M | 5.2M | 161K | 964K | 915.8K | |
Property Plant Equipment | 89.3M | 111.5M | 406.4M | 300.0M | 345.0M | 214.9M |
Pair Trading with Burning Rock
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Burning Rock position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Burning Rock will appreciate offsetting losses from the drop in the long position's value.Moving together with Burning Stock
Moving against Burning Stock
0.85 | DMAC | DiaMedica Therapeutics Earnings Call This Week | PairCorr |
0.76 | DNLI | Denali Therapeutics | PairCorr |
0.71 | DSGN | Design Therapeutics Earnings Call This Week | PairCorr |
0.67 | DOMH | Dominari Holdings | PairCorr |
0.63 | VCYT | Veracyte | PairCorr |
The ability to find closely correlated positions to Burning Rock could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Burning Rock when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Burning Rock - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Burning Rock Biotech to buy it.
The correlation of Burning Rock is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Burning Rock moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Burning Rock Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Burning Rock can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Burning Stock Analysis
When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.